Application of Single-Use Technologies (SUT) in Biosimilar Development Kumar Jeetendra | July 4, 2022 The current processing paradigm of large manufacturing facilities dedicated to single-product production is no longer an effective approach for best manufacturing practices. Additionally, in recent years, patents on several blockbuster biologics have expired, which means leading pharmaceutical companies can no longer charge a premium for these products. The subsequent launch of biosimilar drugs, which can …
Biosimilars vs. Biologics: Breaking Down the Similarities and Differences Kumar Jeetendra | October 14, 2023 Although both biologics and biosimilars are significant drug classes utilized in healthcare, they differ in terms of their properties, approval processes, and price points. Here’s a breakdown of their similarities and differences: Biologics: Origin: Complex medications known as biologics are derived from living things like bacteria, yeast, or mammalian cells. They consist of medicinal proteins, …
